• Featured Product
  • KD/KO Validated

SLC35F2 Polyclonal antibody

SLC35F2 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, IP, ELISA

Conjugate

Unconjugated

Cat no : 25526-1-AP

Synonyms

HSNOV1, SLC35F2



Tested Applications

Positive WB detected inA549 cells, mouse brain tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 25526-1-AP is SLC35F2 Fusion Protein expressed in E. coli.

Tested Reactivity human, mouse
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SLC35F2 fusion protein Ag20901
Full Name solute carrier family 35, member F2
Calculated Molecular Weight 374 aa, 41 kDa
Observed Molecular Weight 41-50 kDa
GenBank Accession NumberBC039195
Gene Symbol SLC35F2
Gene ID (NCBI) 54733
RRIDAB_2880119
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

SLC35F2, also named as Solute carrier family 35 member F2, is a 374 amino acid protein, which belongs to the SLC35F solute transporter family. SLC35F2 as a Multi-pass membrane protein is a putative solute transporter. SLC35F2 is highly homologous to the lung squamous cell cancer-related gene, LSCC3, which is highly expressed in lung squamous cell tumour tissues. However, the clinical implication of the SLC35F2 gene in tumour development and progression remains unclear.

Protocols

Product Specific Protocols
WB protocol for SLC35F2 antibody 25526-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Theranostics

USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2

Authors - Arun Pandian Chandrasekaran
humanWB

Mol Cancer Res

Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.

Authors - Michael D Nyquist
humanWB,IP

Biochem Biophys Res Commun

βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells

Authors - Jencia Carminha Colaco
humanWB

Onco Targets Ther

Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.

Authors - Mei Chen
  • KD Validated
humanWB

Biochim Biophys Acta Gen Subj

E3 ubiquitin ligase APC/CCdh1 regulates SLC35F2 protein turnover and inhibits cancer progression in HeLa cells

Authors - Jencia Carminha Colaco